REM parameters in drug-free major depressive disorder: A systematic review and meta-analysis

Sleep Med Rev. 2024 Feb:73:101876. doi: 10.1016/j.smrv.2023.101876. Epub 2023 Nov 20.

Abstract

Previous studies revealed that rapid eye movement (REM) parameters, such as REM latency (RL) and REM density (RD) could be used as electrophysiological markers of depression. Yet these finding should be re-tested in a comorbid-free and drug-free sample. The present systematic review and meta-analysis was conducted to investigate whether drug-free and comorbid-free patients with unipolar depression differentiate from controls with respect to the RL and RD. The PubMed and Web of Science databases were screened from inception to 23 January 2023 for case-control studies comparing RL and RD of patients with unipolar depression and controls. The primary outcome was the standard mean difference. The data were fitted with a random-effects model. Meta-regressions were conducted to investigate patient characteristics and effect size. Publication bias assessment was checked by Egger's Regression and funnel plot asymmetry. Among 43 articles accepted as eligible, 46 RL and 22 RD measurements were included in the meta-analysis. The results indicated shortened RL and increased RD in the patient group than controls. Neither Egger's regression nor funnel plot asymmetry were significant for publication bias. In conclusion, our results tested within drug-free and comorbid-free samples are in line with the literature.

Keywords: Biomarker; Major depressive disorder; Meta-analysis; Polysomnography; REM density; REM latency; Sleep EEG.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Case-Control Studies
  • Depressive Disorder, Major*
  • Humans
  • Sleep, REM* / physiology